Research tradition

The scientists Cécile und Oskar Vogt, between them N. W. Timoféeff-Ressovsky

The scientists Cécile und Oskar Vogt, between them N. W. Timoféeff-Ressovsky

Medical-biological research has a 75-year tradition at Berlin-Buch. Here in 1930 the Institute for Brain Research of the Kaiser Wilhelm Association with the affiliated neurological clinic was established, with Oskar Vogt as director. At that time the institute was the largest and most modern of its kind in the world. Vogt's work focused on histological-anatomic and functional layer- and field structures (topistic) of the cerebral cortex. From 1937 on, Vogt's successor directed the institute's research onto various neuropathological problems including brain tumors. The institute achieved special renown through the work of the Russian geneticist  N. W. Timoféeff-Ressovsky  on gene mutations and the structure of the gene, in part together with Max Delbrück.

At Work: the geneticist Timoféeff-Ressovsky

At Work: the geneticist Timoféeff-Ressovsky

In 1947 the institute and clinic were combined as the Institute for Medicine and Biology and placed under the auspices of the German Academy of Sciences in Berlin. The institute became a well-known center for cancer research with research projects on the chemical genesis of cancer, oncogenic viruses, biochemistry, immunology, genetics and radiobiology as well as the clinical treatment of tumors. From 1956 onward, a second emphasis was placed on cardiovascular research, likewise integrating research and clinical practice. In 1972 the different Academy research institutes at Buch merged to form the central institutes for molecular biology, for cancer research and for cardiovascular research.

The former Robert Rössle Hospital, the so-called Tumor Clinic

The former Robert Rössle Hospital, the so-called Tumor Clinic 

With the unification of West and East Germany in 1990, the academy institutes were phased out in accordance with the unification agreement. Subsequently, the  Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch was founded on the Campus in 1992. Starting in 1995, biotechnology companies have settled on the Campus in the Innovation and Founding Center. In 2000 the Leibniz Institute for Molecular Pharmacology (FMP) was established.

Since 2011 the Experimental and Clinical Research Center (ECRC) has been housed in the Robert Rössle Building of the former Tumor Clinic. The ECRC is a joint institution of the Berlin Charité and the Max Delbrück Center with research departments and outpatient clinics of different medical departments.

Building of the Institute for Brain Research of the Kaiser Wilhelm Society, now named after the founders Cécile and Oskar Vogt

Building of the Institute for Brain Research of the Kaiser Wilhelm Society, now named after the founders Cécile and Oskar Vogt

News Buch Berlin

A Leap into the World of Big Pharma

The Successful Transformation of a Startup: An Interview with Dr. Christian Regenbrecht, Vice President of Translational Oncology at GSK and Founder of CELLphenomics

more ...

Alithea Bio Scores Double Victory at VivaTech 2026 for Breakthrough in Preclinical Safety

Deep-tech biotech innovator Alithea Bio has achieved a spectacular double victory at VivaTech 2026, Europe’s largest startup and tech event, taking home both the coveted “Tech for Change” Jury Prize a...

more ...

Eckert & Ziegler SE Annual General Meeting Approves Significantly Higher Dividend

The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of € 0.22 per share (previ...

more ...

Events Buch Berlin

09.07.2026, 17:00
Festival der Gesundheit

Workshops zu Schlaf, Kreativität, Entspannung und Freundschaft

more ...

27.08.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung (Verschoben vom 4. Juni auf 27. August)

Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...

more ...

22.09.2026, 09:00
GMP Biotech Summer School

Knowing and applying the Good Manufacturing Practice (GMP) regulations is one of the key elements in the manufacture of medicinal products for clinical trials and on an industrial level.

more ...

This website is supported by: